Dianthus Therapeutics Banner

Analyst Coverage

Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer

Firm Analyst
Yatin Suneja
Raymond James
Steven Seedhouse

Dianthus Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Dianthus Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dianthus Therapeutics or its management. Dianthus Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.